The Myth: If It Sells Here, It Can Sell Anywhere

Many founders assume that once a product is approved in Australia, it can be sold everywhere. The reality is more complex. Cosmetic regulations differ significantly across the globe. What passes in Australia may be restricted in the EU, reclassified in Japan, or require new submissions in China. Even within the United States, new federal laws and state-specific requirements are changing how cosmetics are regulated. We’ve seen brands celebrate a successful launch at home, only to discover that their hero ingredient was banned in Europe, or their packaging claims violated US law. The result? Costly reformulations, relaunch delays, and in some cases, entire product ranges pulled from shelves. In today’s global beauty market, compliance isn’t a box to tick — it’s a foundation for sustainable growth.

The Risks of Overlooking Compliance

Ignoring compliance differences across regions can create setbacks that are difficult — and expensive — to recover from.

1. Ingredient Restrictions

• Australia (AICIS): Requires all industrial chemicals, including cosmetic ingredients, to be registered. Some ingredients have concentration limits.

• European Union (EC No 1223/2009): Maintains one of the strictest banned and restricted ingredient lists globally. For example, certain preservatives and fragrance allergens are restricted to very low levels.

• United States (FDA): Focuses less on pre-market approval but strictly enforces against unsafe or misbranded products. Colour additives and certain claims are heavily regulated.

• Canada (Health Canada): Requires compliance with a restricted ingredient list and notification of all cosmetics sold within 10 days.

• Japan (PMD Act): Products may be classified as quasi-drugs if they make certain claims (e.g. whitening, anti-dandruff). These require extra approvals.

An ingredient that is legal in Australia may be banned in the EU. Using it without checking global standards can prevent expansion.

2. Claims and Marketing Language

Marketing language can shift a cosmetic into a therapeutic or drug category:

• Australia (TGA): Claims like “treats acne” can reclassify a product as therapeutic.

• US: The FDA actively enforces against “drug-like” claims.

• EU: “Free from” claims are restricted if they mislead consumers.

• Japan: Many common cosmetic claims (e.g. “anti-aging”) place products into quasi-drug status.

3. Testing and Documentation

• Stability and Safety Testing: Required in all markets to ensure products remain safe and effective over time.

• Product Information Files (EU): Mandatory for EU entry, including safety assessments and testing results.

• Notification Systems: The EU requires products to be registered on the CPNP (Cosmetic Product Notification Portal). Australia requires record-keeping with AICIS.

• US (under MoCRA): From 2025, brands must maintain substantiated safety data and report adverse events.

The Cost of Getting It Wrong

Compliance oversights are expensive.

• Relaunch delays → Reformulating and retesting can take months.

• Pulled stock → Products may be withdrawn from shelves if found non-compliant.

• Retailer trust → Retailers require compliance assurance. Once trust is broken, it’s hard to win back.

• Financial loss → Reformulation costs, lost sales, and legal penalties add up quickly.

We’ve seen brands forced to reformulate entire ranges because one preservative exceeded EU limits. The cost wasn’t just financial — it damaged their credibility with distributors and retailers.

Global Compliance at a Glance

Here’s a simplified breakdown of how regulations differ across key markets:

Australia

• Overseen by AICIS (Australian Industrial Chemicals Introduction Scheme).

• All cosmetic ingredients must be registered.

• TGA oversees products making therapeutic claims.

• Testing: Stability, preservative efficacy, safety documentation expected.

European Union

• Governed by Cosmetics Regulation (EC No 1223/2009).

• Strict banned and restricted substance list (over 1,600 banned ingredients).

• Mandatory Product Information File (PIF) and Cosmetic Product Safety Report (CPSR).

• Products must be registered on the CPNP before sale.

• Requires a Responsible Person based in the EU.

United States

• Overseen by the FDA.

• No pre-market approval for most cosmetics (exceptions for colour additives).

• Strong enforcement on safety and misbranding.

• Claims like “anti-aging” or “treats acne” can trigger drug classification.

• Historically no pre-market approval, but the Modernisation of Cosmetics Regulation Act (MoCRA, 2022) is phasing in from 2025.

Canada

• Overseen by Health Canada.

• Requires cosmetic notification within 10 days of sale.

• Enforces bilingual labelling and compliance with a restricted ingredient list.

Japan

• Regulated under the Pharmaceutical and Medical Device Act (PMD Act).

• Many products are classified as quasi-drugs if they claim efficacy, requiring additional testing and approvals.

The Smart Play: Future-Proof Your Formula

The smartest brands plan for global compliance from day one. That means:

• Choosing globally cleared ingredients. Using ingredients that meet EU restrictions, AICIS registration, and FDA allowances reduces reformulation risks later.

• Building compliance into development. Don’t wait until launch to check regulations. Compliance checks should sit alongside R&D and formulation testing.

• Future-proofing your claims. Decide early whether your product will remain cosmetic or if it may cross into therapeutic territory.

• Planning for scale. If you intend to export, build compliance into your roadmap. It’s easier to design a compliant product upfront than to retrofit later.

• Think beyond one market. Even if you’re launching in Australia first, plan for international expansion.

How We Support Brands at Labwork

Compliance isn’t an afterthought — it’s embedded into how we work, especially at the early stages of product development.

• Ingredient vetting: We select ingredients with AU, US, and EU compliance in mind.

• Transparent compliance guidance: We guide clients through AICIS, TGA, EU, and FDA requirements.

• Documentation support: From stability testing to PIF preparation, we help build the evidence retailers and regulators demand.

• Future-proof formulations: We design products that not only meet today’s standards but are built to scale into international markets.

This approach protects brands from costly mistakes and ensures products are built on a foundation of trust and longevity.

Final Takeaway

Compliance blind spots are one of the biggest hidden risks in cosmetic product development. What’s legal in one country may be restricted in another — and ignoring these differences can lead to relaunch disasters. By planning for compliance early, choosing globally approved ingredients, and partnering with the right lab, you can avoid costly reformulations and launch with confidence.

Want to expand globally without compliance headaches? Contact Labwork — Australia’s trusted cosmetic chemist and manufacturer — and let’s build a formula that lasts worldwide.

-

References / Sources

AICIS (Australian Industrial Chemicals Introduction Scheme).
“Cosmetic regulations and ingredient registration in Australia.”
https://www.industrialchemicals.gov.au

TGA (Therapeutic Goods Administration).
“Cosmetic vs therapeutic goods in Australia.”
https://www.tga.gov.au

European Union Regulation (EC No 1223/2009).
“Cosmetics Regulation — safety, banned lists, and compliance requirements.”
https://health.ec.europa.eu

US FDA.
“FDA Authority Over Cosmetics: What Manufacturers Need to Know.”
https://www.fda.gov

Health Canada – Cosmetic Regulations.
https://www.canada.ca/en/health-canada/services/cosmetics

Japan PMDA – Cosmetic Oversight.
https://www.pmda.go.jp/english